NCT00571701: Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis |
|
|
| Completed | 2 | 50 | US | celebrex (celecoxib), Celebrex, placebo | Northwell Health, National Institute on Deafness and Other Communication Disorders (NIDCD), University of Iowa, Eastern Virginia Medical School, University of Alabama at Birmingham, University of California, San Francisco, Vanderbilt University, Sanford Health, Weill Medical College of Cornell University | Recurrent Respiratory Papillomatosis | 01/15 | 01/15 | | |
